Home › NDC Lookup › Ingredients › Miconazole Nitrate › 50066-0084-46
Silka Athletes Foot MICONAZOLE NITRATE 20 mg/g Aerosol, Spray, 130 g — NDC 50066-0084-46 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Silka Athletes Foot MICONAZOLE NITRATE 20 mg/g Aerosol, Spray, 130 g — NDC 50066-084-46 (Billing 50066-0084-46)

by Genomma Lab USA · 130 g in 1 CANISTER

This is a package of 130 g of Silka Athletes Foot MICONAZOLE NITRATE 20 mg/g Aerosol, Spray from Genomma Lab USA, marketed since Feb 2025 and currently FDA-listed. It is this product's only package size.

NDC 50066-0084-46
🏷️ FDA NDC (as labeled) 50066-084-46 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 50066-084-46 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
50066 labeler · 084 product · 46 package
Package marketed since
Feb 3, 2025
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 5006608446 0
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Miconazole Nitrate (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Jan 10, 2024 — Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of the formulation/ ingredient list. (MEDLINE INDUSTRIES, LP - Northfield) · FDA recall D-0315-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 50066-084-46
Product NDC 50066-084
11-digit billing NDC 50066008446
RxCUI 998428, 2704865
UNII VW4H1CYW1K
Application # M005
SPL Set ID 307104a2-2df6-43b0-bf3f-f4d93d3e40f1
Established class (EPC) Azole Antifungal
Chemical class Azoles
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-02-03
Route TOPICAL
Dosage form AEROSOL, SPRAY
Substance MICONAZOLE NITRATE
Quick answers
  • RxCUI (RxNorm): 998428
Why two NDCs? The FDA registers this code as 50066-084-46 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 50066-0084-46. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Azole Antifungal class.

Pharmacologic class Azole Antifungal
Drug family (ATC) Antiinfectives and antiseptics for local oral treatment, Imidazole derivatives, Imidazole and triazole derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 What it is MedlinePlus · NLM

Topical miconazole is used to treat tinea corporis(ringworm; fungal skin infection that causes a red scaly rash on different parts of the body), tinea cruris (jock itch; fungal infection of the skin in the groin or buttocks), and tinea pedis (athlete's foot; fungal infection of the skin on the feet and between the toes). Miconazole is in a class of antifungal medications called imidazoles. It works by stopping the growth of fungi that cause infection. Not all products should be used to treat all of these conditions. Please read the label for each product to select the one to treat your conditi...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It treats fungal and yeast infections. Depending on the product, that means vaginal yeast infections, athlete's foot, jock itch, ringworm, or thrush in the mouth and throat (Oravig...
  • Apply it to your upper gum in the morning after brushing, with dry hands. Hold it in place for 30 seconds. Don't crush, chew or swallow it. Use it once a day for 14 days.
  • Most are mild, like diarrhea, nausea, headache, upper belly pain or a change in taste. Vaginal products may cause mild burning or itching at first. Stop and get help for hives, tro...
  • Tell me if you take warfarin. Miconazole can boost its blood-thinning effect, so watch for bleeding or bruising. With Oravig, oral diabetes medicines, phenytoin and ergot alkaloids...
📖 Read our full Miconazole guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
50066-0084-46 You're viewing this Main listing 130 g in 1 CANISTER 2025-02-03 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Miconazole Nitrate 2.6 g/130g 70000-0321-01 Cardinal 130 g $0.036 — Availability likely —
Miconazole Nitrate 2.6 g/130g 00363-7418-00 Walgreens 130 g — — FDA listed —
Lotrimin AF Jock Itch 20 mg/g 11523-0133-01 Bayer 133 g — — FDA listed —
Lotrimin AF 20 mg/g 11523-0134-01 Bayer 133 g — — FDA listed —
Lotrimin AF Deodorant 20 mg/g 11523-0135-01 Bayer 133 g — — FDA listed —
Miconazole Nitrate 2.6 g/130g 11822-0135-04 Rite 130 g — — FDA listed —
Miconazole Nitrate 2.6 g/130g 21130-0212-00 Better 130 g — — FDA listed —
Good Neighbor Pharmacy Jock Itch Relief Antifungal 20 mg/g 23667-0819-01 Formulated 130 g — — Discontinued —
Miconazole Nitrate 2.6 g/130g 36800-0384-46 Topco 130 g — — FDA listed —
Miconazole Nitrate 2.6 g/130g 41250-0196-46 Meijer 130 g — — Discontinued —
Miconazole Nitrate 2.6 g/130g 41520-0565-46 Foodhold 130 g — — FDA listed —
Silka Athletes Foot 20 mg/gthis 50066-0084-46 Genomma 130 g — — FDA listed —
Miconazole Nitrate 2.6 g/130g 56104-0121-01 Premier 130 g — — FDA listed —
Miconazole Nitrate 2.6 g/130g 56104-0131-46 Premier 130 g — — Discontinued —
Miconazole Nitrate 20 mg/g 56104-0907-01 Premier 130 g — — FDA listed —
Athletes Foot 20 mg/g 56104-0912-01 Premier 130 g — — FDA listed —
HEB Athlete Foot Antifungal 20 mg/g 59640-0101-01 HEB 130 g — — FDA listed —
Miconazole Nitrate 2.6 g/130g 63868-0180-46 Chain 130 g — — FDA listed —
Miconazole Nitrate 2.6 g/130g 67091-0392-06 Winco 130 g — — FDA listed —
Miconazole Nitrate 2.6 g/130g 69256-0039-46 Harris 130 g — — FDA listed —
Miconazole Nitrate 2.6 g/130g 69842-0511-46 CVS 130 g — — FDA listed —
Antifungal Athletes Foot 20 mg/g 79481-0505-01 Meijer 130 g — — FDA listed —
Jock Itch 20 mg/g 79481-0602-01 Meijer 130 g — — FDA listed —
Miconazole Nitrate 2.6 g/130g 79903-0014-46 Wal-Mart 130 g — — FDA listed —
Miconazole Nitrate 20 mg/g 83324-0233-46 Chain 130 g — — FDA listed —
Antifungal Miconazole Liquid Continuous 20 mg/g 79481-0599-01 Meijer 150 g — — FDA listed —
Antifungal Liquid Continuous 20 mg/g 55319-0539-01 Family 150 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Feb 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 4B96DT2BYB
    A synthetic fluorinated organic chemical used as a propellant in pressurized aerosol inhalers and sprays. It helps deliver the active medication as a fine mist to the lungs or target site.
  • UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • UNII 7T1F30V5YH
    A synthetic emulsifier derived from sorbitol and oleic acid. It helps mix oil and water-based ingredients together and keeps them from separating in liquid formulations.

3 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesAlcohol Denat., polysorbate 20, tetrafluoropropene

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerGenomma Lab USA
FDA applicationM005 (OTC MONOGRAPH DRUG)
Labeler code50066
First marketedFeb 2025
Product typeHuman Otc Drug
Portfolio29 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 25 words ▾

Uses Clinically proven to be effective in the treatment of most athlete's foot (tinea pedis) Provides effective relief of itching, cracking, burning, scaling, and discomfort.

⏱️ Dosage and Administration 65 words ▾

Directions wash affected area and dry thoroughly shake can well and spray a thin layer over affected area twice daily (morning and night) supervise children in the use of this product for athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes and change shoes and socks at least once daily this product is not effective on the scalp or nails

⚠️ Warnings 116 words ▾

Warnings For external use only. Flammable . Do not use while smoking or near heat or flame.

Do not use on children under 2 years of age unless directed by a doctor. When using this product Avoid contact with eyes in case of contact with eyes, flush thoroughly with water Avoid applying on broken skin do not inhale or ingest contents under pressure. Do not puncture or incinerate.

Do not store at temperature above 120°F Stop use and ask a doctor if irritation occurs there is no improvement within 4 weeks (for athlete's foot) Keep out of the reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 10 words ▾

Other information store between 20° to 25° (68° to 77°F)

🧪 Active Ingredient 5 words ▾

Active ingredient Miconazole nitrate 2%

🧪 Inactive Ingredients 7 words ▾

Inactive ingredients Alcohol Denat., polysorbate 20, tetrafluoropropene

🎯 Purpose 2 words ▾

Purpose Antifungal

📄 Do Not Use 15 words ▾

Do not use on children under 2 years of age unless directed by a doctor.

📄 When Using This Product 43 words ▾

When using this product Avoid contact with eyes in case of contact with eyes, flush thoroughly with water Avoid applying on broken skin do not inhale or ingest contents under pressure. Do not puncture or incinerate. Do not store at temperature above 120°F

📄 Stop Use and Ask a Doctor If 19 words ▾

Stop use and ask a doctor if irritation occurs there is no improvement within 4 weeks (for athlete's foot)

📄 Keep Out of Reach of Children 22 words ▾

Keep out of the reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 10 words ▾

Questions? 1-877-994-3666 Monday to Friday, 8am to 6pm Central time.

📄 Package Label / Principal Display Panel 45 words ▾

PRINCIPAL DISPLAY PANEL - 130 g Canister Label SILKA ® ATHLETE'S FOOT POWDER SPRAY Miconazole nitrate 2% - antifungal CLINICALLY PROVEN TO CURE MOST ATHLETE'S FOOT* HELPS RELIEVE BAD ODOR ITCHING SWEATING BURNING Net Wt 4.6oz (130g) Principal Display Panel - 130 g Canister Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Miconazole 3 (matched by generic name) — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Miconazole 3. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$35.6K
Claims incl. refills
725
Beneficiaries
649
Spend / beneficiary
$54.91
Spend / claim
$49.15
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Genomma Lab USA. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Genomma Lab USA is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.